Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The American Journal of Surgical Pathology|January 9, 2020
Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid FibrosarcomaFlorian Puls, Abbas Agaimy, Uta Flucke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment TargetsElsa Arbajian, Florian Puls, Cristina R Antonescu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 31, 2021
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumorFlorian Puls, Jodi M Carter, Nischalan Pillay, et al.
Plos One|June 1, 2013
Lymphoid aggregates that resemble tertiary lymphoid organs define a specific pathological subset in metal-on-metal hip replacementsSaloni Mittal, Matthew Revell, Francesca Barone, et al.
The American Journal of Surgical Pathology|December 21, 2018
PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 CasesFlorian Puls, Nischalan Pillay, Henrik Fagman, et al.
The Journal of Pathology|November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathwayKarim H Saba, Valeria Difilippo, Michal Kovac, et al.
Virchows Archiv : an International Journal of Pathology|February 8, 2024
Small cell osteosarcoma versus fusion-driven round cell sarcomas of bone: retrospective clinical, radiological, pathological, and (epi)genetic comparison with clinical implicationsLaura S Hiemcke-Jiwa, Vaiyapuri P Sumathi, Daniel Baumhoer, et al.
The Journal of Pathology. Clinical Research|June 17, 2020
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastomaKarim H Saba, Louise Cornmark, Jakob Hofvander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2025
FET-rearranged Myoepithelial Tumors are Clinically Heterogeneous and Epigenetically Distinct from PLAG1-rearranged Adnexal and Salivary Gland Myoepithelial TumorsMichael Michal, Faizan Malik, Boulos Mansour, et al.
Pageof 3